BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perler BK, Ungaro R, Baird G, Mallette M, Bright R, Shah S, Shapiro J, Sands BE. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol 2019;19:47. [PMID: 30940072 DOI: 10.1186/s12876-019-0963-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Larussa T, Abenavoli L, Fabiano G, Mancuso MA, Polimeni N, Dumitrascu DL, Luzza F. Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. Minerva Gastroenterol 2021;67. [DOI: 10.23736/s2724-5985.21.02907-7] [Reference Citation Analysis]
2 Perler BK, Ungaro R, Baird G, Mallette M, Bright R, Shah S, Shapiro J, Sands BE. Correction to: Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol 2020;20:406. [PMID: 33272202 DOI: 10.1186/s12876-020-01526-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Konjar Š, Pavšič M, Veldhoen M. Regulation of Oxygen Homeostasis at the Intestinal Epithelial Barrier Site. Int J Mol Sci 2021;22:9170. [PMID: 34502078 DOI: 10.3390/ijms22179170] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kang K, Sun Y, Pan D, Chang B, Sang LX. Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota. J Immunol Res 2021;2021:5084713. [PMID: 33748287 DOI: 10.1155/2021/5084713] [Reference Citation Analysis]
5 Damas OM, Abreu MT. Digging Deeper to Increase Understanding of Endoscopic and Histopathology Risk Factors for Progression of Dysplasia in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2020;18:1433-5. [PMID: 31751772 DOI: 10.1016/j.cgh.2019.11.027] [Reference Citation Analysis]
6 Ealing I, Ben-David M. Simultaneous colocutaneous and colojejunal fistula as initial presentation in Crohn's disease. ANZ J Surg 2021. [PMID: 34273132 DOI: 10.1111/ans.17082] [Reference Citation Analysis]
7 El-Atrebi KA, Taher E, El Aguizy FH, Ali RM, Hegazy A, El-Sayed MM, Eysa B, El-Atreby AA, Mohammed AA, El-Bassyouni HT. A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00131-6. [PMID: 34887218 DOI: 10.1016/j.rgmxen.2021.11.015] [Reference Citation Analysis]
8 Naegeli AN, Balkaran BL, Shan M, Hunter TM, Lee LK, Jairath V. The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study. Curr Med Res Opin 2022;:1-26. [PMID: 35175166 DOI: 10.1080/03007995.2022.2043655] [Reference Citation Analysis]
9 Murray FR, Morell B, Biedermann L, Schreiner P. Protein-losing enteropathy as precursor of inflammatory bowel disease: a review of the literature. BMJ Case Rep 2021;14:e238802. [PMID: 33431540 DOI: 10.1136/bcr-2020-238802] [Reference Citation Analysis]
10 Ivashkin VT, Shelygin YA, Belousova EA, Abdulganieva DI, Alekseeva OA, Achkasov SI, Valuiskikh EY, Vardanyan AV, Veselov AV, Veselov VV, Golovenko OV, Gubonina IV, Zhigalova TN, Kashnikov VN, Knyazev OV, Makarchuk PA, Moskaliev AI, Nanaeva BA, Nizov AA, Nikitina NV, Nikolaeva NN, Pavlenko VV, Poluektova EA, Svetlova IO, Tarasova LV, Tkachev AV, Frolov SA, Khlynova OV, Chashkova EY, Shapina MV, Sheptulin AA, Shifrin OS, Shchukina OB. PROJECT: CLINICAL GUIDELINES FOR THE DIAGNOSTICS AND TREATMENT OF ULCERATIVE COLITIS. Koloproktologiâ 2019;18:7-36. [DOI: 10.33878/2073-7556-2019-18-4-7-36] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 5.3] [Reference Citation Analysis]
11 Libera J, Wittner M, Kantowski M, Woost R, Eberhard JM, de Heer J, Reher D, Huber S, Haag F, Schulze Zur Wiesch J. Decreased Frequency of Intestinal CD39+ γδ+ T Cells With Tissue-Resident Memory Phenotype in Inflammatory Bowel Disease. Front Immunol 2020;11:567472. [PMID: 33072107 DOI: 10.3389/fimmu.2020.567472] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Baker RD, Baker SS. Gastrointestinal Bleeds. Pediatr Rev 2021;42:546-57. [PMID: 34599054 DOI: 10.1542/pir.2020-000554] [Reference Citation Analysis]
13 Légeret C, Rüttimann C, Fankhauser H, Köhler H. Parasitic infections in Swiss children: Are we overtesting? BMC Gastroenterol 2021;21:39. [PMID: 33499814 DOI: 10.1186/s12876-021-01619-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ajbar A, Cross E, Matoi S, Hay CA, Baines LM, Saunders B, Farmer AD, Prior JA. Diagnostic Delay in Pediatric Inflammatory Bowel Disease: A Systematic Review. Dig Dis Sci 2022. [PMID: 35288834 DOI: 10.1007/s10620-022-07452-5] [Reference Citation Analysis]
15 Fletcher J, Cooper SC, Swift A. Patient-Reported Outcomes in Inflammatory Bowel Disease: A Measurement of Effect in Research and Clinical Care. Gastroenterology Insights 2021;12:225-37. [DOI: 10.3390/gastroent12020020] [Reference Citation Analysis]
16 Wei S, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJQ, Koram N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Review of Gastroenterology & Hepatology 2021;15:275-89. [DOI: 10.1080/17474124.2021.1840976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lashgari NA, Roudsari NM, Zandi N, Pazoki B, Rezaei A, Hashemi M, Momtaz S, Rahimi R, Shayan M, Dehpour AR, Abdolghaffari AH. Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations. Mol Biol Rep 2021;48:855-74. [PMID: 33394234 DOI: 10.1007/s11033-020-06095-x] [Reference Citation Analysis]
18 Park YT, Kim T, Ham J, Choi J, Lee HS, Yeon YJ, Choi SI, Kim N, Kim YR, Seok YJ. Physiological activity of E. coli engineered to produce butyric acid. Microb Biotechnol 2021. [PMID: 33729711 DOI: 10.1111/1751-7915.13795] [Reference Citation Analysis]
19 Coates MD, Soriano C, Dalessio S, Stuart A, Walter V, Koltun W, Bernasko N, Tinsley A, Clarke K, Williams ED. Gastrointestinal hypoalgesia in inflammatory bowel disease. Ann Gastroenterol 2020;33:45-52. [PMID: 31892797 DOI: 10.20524/aog.2019.0442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Singhal R, Shah YM. Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine. J Biol Chem 2020;295:10493-505. [PMID: 32503843 DOI: 10.1074/jbc.REV120.011188] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
21 Lu Q, Fu Y, Li H. Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders. Pharmacol Rep 2022. [PMID: 35083737 DOI: 10.1007/s43440-021-00348-7] [Reference Citation Analysis]